Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative recombinant human erythropoietin in anemic patients undergoing THA/TKA
ChiCTR-IPR-15005959Phase 4Not yet recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Mar 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of erythropoietin in anaemia, hip osteoarthritis and knee osteoarthritis (OA) (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoint: Hemoglobin (Hb). Planned start Mar 2015; status: not yet recruiting.
02
Drugs
erythropoietin
03
Conditions
anaemiahip osteoarthritisknee osteoarthritis (OA)
Beyond the preview
Go deeper on ChiCTR-IPR-15005959.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-15005959.